MDT and LGND Related Headlines
Go Back- Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
- Orchestra BioMed receives $15 million from Ligand under financing agreement
- Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
- Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
- Orchestra BioMed raises $111 million through equity offerings and partnerships
- Ligand and Medtronic invest $70 million in Orchestra BioMed
- Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
MDT and LGND Related Press Releases
Go Back- Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
- Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
- Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
- Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
